Company profile: Synaptic Medical
1.1 - Company Overview
Company description
- Provider of medical devices for cryoablation and cardiac procedures, including the Nordica Cryo Console and Nordica Balloon Catheter (both under investigation), a Pulmonary Vein Mapping Catheter, NaviGo 12F and NaviEase intracardiac catheter introducer kits, and the AKS Transseptal Needle for transseptal access.
Products and services
- Nordica Balloon Catheter: An investigational cryo balloon catheter intended for use in cryoablation procedures, featuring a balloon catheter format for cryoablation applications
- Nordica Cryo Console: An investigational device developed for cryoablation procedures, functioning as the dedicated console component for cryoablation during ongoing investigation
- Pulmonary Vein Mapping Catheter: A diagnostic-grade mapping catheter used to map the pulmonary veins, delivering catheter-based mapping of pulmonary veins as specified
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synaptic Medical
TYRX
HQ: United States
Website
- Description: Provider of medical-pharmaceutical combination devices and resorbable polymeric biomaterials delivering site-specific therapy for multiple surgical markets. Offers PIVIT CRM, a mesh-based pouch with antibacterial agents to protect against microbial colonization of the generator or defibrillator during and immediately after surgical implant; also provides AIGISRx.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TYRX company profile →
Rivus Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical, oral small-molecule Controlled Metabolic Accelerators (CMAs) that activate mitochondrial uncoupling to reduce excess fat, increase energy expenditure, and preserve muscle mass for treating obesity and associated cardiometabolic diseases. Pipeline includes HU6, an investigational CMA, and RV-002, a preclinical ANT activator targeting obesity and cardiovascular disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rivus Pharmaceuticals company profile →
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
SIS Medical
HQ: Switzerland
Website
- Description: Provider of vascular disease treatment products, developed, produced, and sold through its subsidiaries; founded in 2005 and headquartered in Winterthur, Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SIS Medical company profile →
BG Medicine
HQ: United States
Website
- Description: Provider of biomarker-based diagnostic tests for the cardiovascular sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BG Medicine company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synaptic Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synaptic Medical
2.2 - Growth funds investing in similar companies to Synaptic Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synaptic Medical
4.2 - Public trading comparable groups for Synaptic Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →